{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:58:02Z","timestamp":1772859482821,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06611-w","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:20:47Z","timestamp":1762971647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and molecular characterization of 148 pediatric neurofibromatosis type 1 patients: a single-center study identifying 14 novel variants"],"prefix":"10.1007","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3847-1364","authenticated-orcid":false,"given":"Asl\u0131","family":"Gen\u00e7","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Cevdet","family":"Ceylan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Altan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"G\u00fcrka\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"\u00d6zy\u00f6r\u00fck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"K\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"1","key":"6611_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1542\/peds.2007-3204","volume":"123","author":"VC Williams","year":"2009","unstructured":"Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL (2009) Neurofibromatosis type 1 revisited. Pediatrics 123(1):124\u2013133. https:\/\/doi.org\/10.1542\/peds.2007-3204","journal-title":"Pediatrics"},{"issue":"1","key":"6611_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.4","volume":"3","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (2017) Neurofibromatosis type 1. Nat Rev Dis Primers 3(1):17004. https:\/\/doi.org\/10.1038\/nrdp.2017.4","journal-title":"Nat Rev Dis Primers"},{"key":"6611_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3160653","volume":"2023","author":"C Chelleri","year":"2023","unstructured":"Chelleri C et al (2023) Somatic double inactivation of NF1 associated with NF1-related pectus excavatum deformity. Hum Mutat 2023:3160653. https:\/\/doi.org\/10.1155\/2023\/3160653","journal-title":"Hum Mutat"},{"issue":"10","key":"6611_CR4","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/gcc.20353","volume":"45","author":"T De Raedt","year":"2006","unstructured":"De Raedt T et al (2006) Somatic loss of wild type NF1 allele in neurofibromas: comparison of NF1 microdeletion and non-microdeletion patients. Genes Chromosomes Cancer 45(10):893\u2013904. https:\/\/doi.org\/10.1002\/gcc.20353","journal-title":"Genes Chromosomes Cancer"},{"key":"6611_CR5","unstructured":"(2020) Cassidy and Allanson\u2019s management of genetic syndromes, 4th ed. Hoboken, New Jersey: Wiley-Blackwell"},{"issue":"2","key":"6611_CR6","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.049362","volume":"15","author":"C Anastasaki","year":"2022","unstructured":"Anastasaki C, Orozco P, Gutmann DH (2022) RAS and beyond: the many faces of the neurofibromatosis type 1 protein. Dis Model Mech 15(2):dmm049362. https:\/\/doi.org\/10.1242\/dmm.049362","journal-title":"Dis Model Mech"},{"issue":"4","key":"6611_CR7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3345\/cep.2020.00871","volume":"64","author":"E Kang","year":"2021","unstructured":"Kang E, Yoon HM, Lee BH (2021) Neurofibromatosis type I: points to be considered by general pediatricians. Clin Exp Pediatr 64(4):149\u2013156. https:\/\/doi.org\/10.3345\/cep.2020.00871","journal-title":"Clin Exp Pediatr"},{"issue":"1","key":"6611_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-018-0483-z","volume":"44","author":"G Corsello","year":"2018","unstructured":"Corsello G et al (2018) Clinical and molecular characterization of 112 single-center patients with neurofibromatosis type 1. Ital J Pediatr 44(1):45. https:\/\/doi.org\/10.1186\/s13052-018-0483-z","journal-title":"Ital J Pediatr"},{"issue":"1","key":"6611_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","volume":"61","author":"KP Boyd","year":"2009","unstructured":"Boyd KP, Korf BR, Theos A (2009) Neurofibromatosis type 1. J Am Acad Dermatol 61(1):1\u201314. https:\/\/doi.org\/10.1016\/j.jaad.2008.12.051","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"6611_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/088307389300800421","volume":"8","author":"K North","year":"1993","unstructured":"North K (1993) Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic. J Child Neurol 8(4):395\u2013402. https:\/\/doi.org\/10.1177\/088307389300800421","journal-title":"J Child Neurol"},{"issue":"7","key":"6611_CR11","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.arcped.2006.03.149","volume":"13","author":"E Bonnemaison","year":"2006","unstructured":"Bonnemaison E et al (2006) Complications de la neurofibromatose de type 1 chez l\u2019enfant\u202f: \u00e0 propos d\u2019une s\u00e9rie de 100 cas. Arch Pediatr 13(7):1009\u20131014. https:\/\/doi.org\/10.1016\/j.arcped.2006.03.149","journal-title":"Arch Pediatr"},{"issue":"6","key":"6611_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/archpedi.1989.02150180099028","volume":"143","author":"AC Obringer","year":"1989","unstructured":"Obringer AC (1989) The diagnosis of neurofibromatosis-1 in the child under the age of 6 years. Arch Pediatr Adolesc Med 143(6):717. https:\/\/doi.org\/10.1001\/archpedi.1989.02150180099028","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"6611_CR13","first-page":"160","volume":"77","author":"K McKeever","year":"2008","unstructured":"McKeever K, Shepherd CW, Crawford H, Morrison PJ (2008) An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age. Ulster Med J 77(3):160\u2013163","journal-title":"Ulster Med J"},{"issue":"5","key":"6611_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.17712\/nsj.2020.5.20200081","volume":"25","author":"FA Bashiri","year":"2020","unstructured":"Bashiri FA, AlZamil LR, Aldhuwayhi RA (2020) Clinical spectrum of neurofibromatosis type 1 among children in a tertiary care center. Neurosciences 25(5):375\u2013379. https:\/\/doi.org\/10.17712\/nsj.2020.5.20200081","journal-title":"Neurosciences"},{"issue":"5","key":"6611_CR15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1067\/mhj.2002.122121","volume":"143","author":"MA Tedesco","year":"2002","unstructured":"Tedesco MA et al (2002) The heart in neurofibromatosis type 1: an echocardiographic study. Am Heart J 143(5):883\u2013888. https:\/\/doi.org\/10.1067\/mhj.2002.122121","journal-title":"Am Heart J"},{"issue":"1","key":"6611_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1824-7288-40-59","volume":"40","author":"E Vargiami","year":"2014","unstructured":"Vargiami E et al (2014) Moyamoya syndrome and neurofibromatosis type 1. Ital J Pediatr 40(1):59. https:\/\/doi.org\/10.1186\/1824-7288-40-59","journal-title":"Ital J Pediatr"},{"issue":"16","key":"6611_CR17","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1212\/WNL.0000000000003881","volume":"88","author":"J Mahdi","year":"2017","unstructured":"Mahdi J et al (2017) A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1. Neurology 88(16):1584\u20131589. https:\/\/doi.org\/10.1212\/WNL.0000000000003881","journal-title":"Neurology"},{"issue":"10","key":"6611_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003043","volume":"95","author":"L Zhu","year":"2016","unstructured":"Zhu L et al (2016) Clinical and molecular characterization of NF1 patients: single-center experience of 32 patients from China. Medicine (Baltimore) 95(10):e3043. https:\/\/doi.org\/10.1097\/MD.0000000000003043","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"6611_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-018-0474-9","volume":"25","author":"Y-H Wu-Chou","year":"2018","unstructured":"Wu-Chou Y-H et al (2018) Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with multiple ligation-dependent probe amplification analysis. J Biomed Sci 25(1):72. https:\/\/doi.org\/10.1186\/s12929-018-0474-9","journal-title":"J Biomed Sci"},{"issue":"8","key":"6611_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/genes10080580","volume":"10","author":"T Giugliano","year":"2019","unstructured":"Giugliano T et al (2019) Clinical and genetic findings in children with neurofibromatosis type 1, Legius syndrome, and other related neurocutaneous disorders. Genes 10(8):580. https:\/\/doi.org\/10.3390\/genes10080580","journal-title":"Genes"},{"issue":"12","key":"6611_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63824","volume":"194","author":"C Chelleri","year":"2024","unstructured":"Chelleri C et al (2024) Novel causative variants in Legius syndrome: SPRED1 genotype spectrum expansion. Am J Med Genet A 194(12):e63824. https:\/\/doi.org\/10.1002\/ajmg.a.63824","journal-title":"Am J Med Genet A"},{"issue":"8","key":"6611_CR22","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","volume":"23","author":"E Legius","year":"2021","unstructured":"Legius E et al (2021) Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation. Genet Med 23(8):1506\u20131513. https:\/\/doi.org\/10.1038\/s41436-021-01170-5","journal-title":"Genet Med"},{"key":"6611_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012436","author":"C Bettegowda","year":"2021","unstructured":"Bettegowda C et al (2021) Genotype-phenotype correlations in neurofibromatosis and their potential clinical use. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000012436","journal-title":"Neurology"},{"issue":"5","key":"6611_CR24","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/jgc4.1303","volume":"29","author":"HB Radtke","year":"2020","unstructured":"Radtke HB, Bergner AL, Goetsch AL, McGowan C, Panzer K, Cannon A (2020) Genetic counseling for Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis\u2014practice resource of the National Society of Genetic Counselors. J Genet Counsel 29(5):692\u2013714. https:\/\/doi.org\/10.1002\/jgc4.1303","journal-title":"J Genet Counsel"},{"issue":"1","key":"6611_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajhg.2017.12.001","volume":"102","author":"M Koczkowska","year":"2018","unstructured":"Koczkowska M et al (2018) Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844\u2013848. Am J Hum Genet 102(1):69\u201387. https:\/\/doi.org\/10.1016\/j.ajhg.2017.12.001","journal-title":"Am J Hum Genet"},{"issue":"4","key":"6611_CR26","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41436-018-0269-0","volume":"21","author":"M Koczkowska","year":"2019","unstructured":"Koczkowska M et al (2019) Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype-phenotype correlation. Genet Med 21(4):867\u2013876. https:\/\/doi.org\/10.1038\/s41436-018-0269-0","journal-title":"Genet Med"},{"issue":"8","key":"6611_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081879","volume":"13","author":"M Scala","year":"2021","unstructured":"Scala M et al (2021) Genotype-phenotype correlations in neurofibromatosis type 1: a single-center cohort study. Cancers (Basel) 13(8):1879. https:\/\/doi.org\/10.3390\/cancers13081879","journal-title":"Cancers (Basel)"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06611-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06611-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06611-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:42:41Z","timestamp":1768459361000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06611-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6611"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06611-w","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki. It was approved by the Clinical Research Ethics Committee with decision number TABED 2\u201324-666. All research procedures followed relevant national and institutional ethical guidelines for studies involving human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"751"}}